AMRX — Amneal Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapSuper Stock

Annual balance sheet for Amneal Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	341	248	26	91.5	111
Net Total Accounts Receivable
Net Total Receivables	674	728	797	646	809
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,552	1,520	1,412	1,378	1,588
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	605	639	589	550	524
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	4,006	3,940	3,799	3,473	3,501
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	677	677	753	847	1,130
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	3,703	3,579	3,501	3,453	3,611
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	303	360	298	19.8	-109
Total Liabilities & Shareholders' Equity	4,006	3,940	3,799	3,473	3,501
Total Common Shares Outstanding
Total Preferred Shares Outstanding